Why the study?
The study was conducted to assess the predictive power of femoral neck bone mineral density and pulse wave velocity for fracture and cardiovascular-related mortality over a 3-year follow-up.
Does pulse wave velocity or femoral neck bone mineral density better predict mortality in a representative cohort?
Does pulse wave velocity or femoral neck bone mineral density better predict mortality in a representative cohort?
Pulse wave velocity is a robust, age-independent prognostic marker for mortality that outperforms femoral neck bone mineral density.
Introduction: This study assessed the predictive power of femoral neck (FN) bone mineral density (BMD) and pulse wave velocity (PWV) for fracture and cardiovascular-related mortality over a three-year follow-up in a representative cohort. Methods: A total of 142 participants (54 males, 38%), aged 56 ± 7.2 years, were enrolled in this prospective observational study. FN BMD was measured using dual-energy X-ray absorptiometry (DXA), and carotid-to-femoral PWV was determined via Doppler ultrasound. Results: Mean PWV was significantly higher in non-survivors compared to survivors (10.9 ± 3.2 m/s vs. 8.6 ± 2.1 m/s, p = 0.0041). FN BMD was lower in non-survivors (0.658 ± 0.131 g/cm²) than in survivors (0.852 ± 0.150 g/cm², p = 0.002). Logistic regression identified PWV as a strong determinant of mortality [coefficient: 0.1593; odds ratio (OR): 1.17; 95% confidence interval (CI): 1.04–1.32; p = 0.01], while FN BMD also showed significance (coefficient: –6.6336; OR: 0.0013; 95% CI: 0.000–0.156; p = 0.0064). However, in age-matched analysis, only PWV remained significant (OR: 2.77; 95% CI: 1.70–4.51; p < 0.0001]. Receiver operating characteristic (ROC) analysis demonstrated superior predictive accuracy for PWV [area under the curve (AUC): 0.958; cutoff: 11.3 m/s; sensitivity: 94.6%; specificity: 88.1%] compared with FN BMD (AUC: 0.560). Conclusion: PWV showed outstanding accuracy for predicting all-cause mortality, outperforming FN BMD and remaining independent of age. These findings establish PWV as a robust prognostic marker for mortality risk, highlighting its potential role in improving clinical risk stratification for vascular aging and cardiovascular outcomes.
No takes yet. Share an insight, caveat, or question.
Avramovska et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: